March 29 2024

FLUVOXAMINE

List of brands containing fluvoxamine   

This page contains a list of brands of authorized pharmaceutical specialties of the active principle fluvoxamine in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Indications and usage     

The active ingredient fluvoxamine belongs to a group of medicines called antidepressants selective reuptake inhibitors (SSRIs).

This drug is indicated for the treatment of:

- Major depressive disorder
- Obsessive-compulsive disorder (OCD).

Medizzine recommends consulting your doctor if you are unsure (or you do not know) why you have been given fluvoxamine.

Other ingredients of the available commercial presentations:

The active substance is fluvoxamine. The other ingredients are mannitol, starch without maize gluten, pregelatinized starch, sodium stearyl fumarate, colloidal anhydrous silica, hypromellose, macrogol 6000, talc and titanium dioxide.

Warning:

The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.

Before taking the drug     

Do not use fluvoxamine

If you are allergic (hypersensitive) to fluvoxamine or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.

Allergy symptoms may include:

- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).

Nor you should take this medicine:

If you are being treated with any medication for depression treatment from a group called monoamine oxidase inhibitors (MAOIs).

Treatment with fluvoxamine can be initiated:

- two weeks after completion of treatment with an irreversible MAOI, or
- the following day after treatment with a reversible MAOI

Must wait at least a week between discontinuation of fluvoxamine and starting the administration of any MAOI.

Take special care with fluvoxamine

When suffering from depressive disorders, there is the possibility of suicide attempt, which may persist until significant improvement occurs.

Fluvoxamine should not normally be used in the treatment of children and adolescents under 18 years except for patients with Obsessive Compulsive Disorder.

At the same time, you should be aware that there is an increased risk of adverse effects such as suicide attempts, suicidal thoughts and hostility (predominantly aggression, oppositional behavior and anger) in patients under age 18 when they take this class of drugs. Despite this, your doctor may prescribe this medicine to patients under 18 years if he considers that this is the most convenient for the patient.

If your doctor has prescribed fluvoxamine to a patient under 18 and you want to discuss this, consult your doctor again. You should inform to doctor if any of the symptoms detailed above occur or worsen when a patient under 18 are taking this medicine. There is no information on the long-term safety in children and adolescents with regards to growth, maturation and cognitive and behavioral development.

- If you have psychomotor agitation.
- If you are being treated with fluvoxamine and treatment is stopped abruptly, dizziness, sleep disturbances, nausea, headache, and fatigue may occur.
- If you have liver or kidney failure or have suffered a myocardial infarction.
- If you have a history of seizures, mania or hypomania.
- If you are being treated with ECT (electroconvulsive therapy).
- If you are being treated with antidiabetic agents, the doctor may need to adjust the dose of these.
- If you have to undergo a blood test, note that there an elevated liver enzymes or hyponatremia (low sodium in the blood) may occur.

Taking other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription.

Absolute contraindication: Fluvoxamine should not be administered in combination with MAOIs.

With many precautions, can be taken together with certain medications that can interact with fluvoxamine; in these cases, it may be necessary to change the dose or stop treatment with any of them:

- Tricyclic antidepressants (p.ej. clomipramine, imipramine, amitriptyline)
- Neuroleptics (e.g. clozapine, olanzapine)
- Other drugs: tacrine, theophylline, methadone, mexiletine, thioridazine, propranolol, caffeine, ropinirole, phenytoin, terfenadine, astemizole, cisapride, carbamazepine, cyclosporine, aspirin, lithium (and possibly tryptophan)
- Benzodiazepines (e.g. triazolam, midazolam, alprazolam, diazepam).
- Other serotonergic agents (including triptans, tramadol, SSRIs, hypericum)
- Oral anticoagulants (warfarin, acenocoumarol).

Use with food and beverages

The blood caffeine levels can increase if taken together to fluvoxamine. Therefore, patients which take large amounts of caffeinated beverages should lower the intake of these products if are treated with fluvoxamine since adverse effects (such as tremor, palpitations, nausea, restlessness, insomnia) may occur.

As with other psychotropic drugs, patients should avoid drinking alcohol while taking fluvoxamine.

Special physiological situations

Pregnancy and lactation

Always consult your doctor or pharmacist before taking any medicine during pregnancy or lactation.

Pregnancy

This drug should be used during pregnancy only if, in the opinion of the doctor, the expected therapeutic benefits justify its use.

Lactation

Fluvoxamine is excreted in breast milk in small amounts. For this reason, it should not be administered to lactating women.

Use in children and adolescents

In children (aged 8 years or older) and adolescents, strict control of the treatment of obsessive compulsive disorders due to lack of safety data related to growth, sexual function, and behavioral development is recommended.

Fluvoxamine use is not recommended in children for the treatment of depression, due to lack of clinical experience.

Use in elderly

In elderly patients, the doctor may consider a dose adjustment.

Driving and using machines

If you are taking fluvoxamine, drowsiness may occur, so it is advisable to refrain from driving or operating machinery until you know how you tolerate the drug.

How to use fluvoxamine     

Follow carefully instructions of use of fluvoxamine provided by your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given in this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.

Your doctor will tell you how long your treatment with this medicine. Do not interrupt it abruptly; Your doctor will tell you how to gradually reduce the dose.

The tablets should be swallowed with water, whole and not chewed.

Depression

Adults:

- The usual effective dose is 100 mg a day.
- The recommended starting dose is 50 mg or 100 mg fluvoxamine, administered as a single dose in the evening.

It is recommended to increase the dose in a gradual way to reach the effective dose.

Children and adolescents:

This drug is not indicated for the treatment of depression in children and adolescents under 18.

Obsessive Compulsive Disorder

Adults:

- The usual effective dose is between 100 mg and 300 mg per day.
- The recommended starting dose is 50 mg, for 3-4 days, administered by the evening.

The dosage should be increased progressively up to the effective dose, with a maximum of 300 mg per day for adults.

Children over 8 years and adolescents:

- The initial dose is 25 mg fluvoxamine.
- The dose should be increased by 25 mg every 4-7 days to reach the effective dose.

The maximum dose in children should not exceed 200 mg a day.

It is recommended that greater than 50 mg daily dose be administered in two doses. If the divided doses are not equal, the larger dose should be administered at bedtime.

Withdrawal symptoms when stopping treatment:

Avoid stop treatment abruptly. Your doctor will reduce the dose gradually to prevent withdrawal symptoms.

Patients with hepatic or renal failure:

These patients should begin treatment with a low dose and be carefully monitored by the doctor.

If you think the effect of the medicine is too strong or too weak, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

While you take fluvoxamine     

If a doctor prescribes another medicine, tell you are taking fluvoxamine.

Check with your doctor regularly developments of disorder that motivates the use of fluvoxamine. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.

Do not restart treatment with fluvoxamine at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.

If you feel unwell during treatment with fluvoxamine, immediately consult your doctor.

If you take more than you should:

Gastrointestinal disturbances (nausea, vomiting, and diarrhea), somnolence and dizziness may occur.

Have been reported cardiovascular effects as tachycardia (rapid heart rate), bradycardia (decreased heart rate), hypotension (low blood pressure), liver function disorders, convulsions, and coma.

If you take more fluoxetine than you should, tell your doctor or go to the nearest hospital casualty department straight away. Take the medicine pack with you, even if it is empty.

If you forget to take fluvoxamine

Do not take a double dose to make up for missed doses.

If you stop taking fluvoxamine

There is the possibility of the withdrawal reactions with cessation of fluvoxamine therapy, although that the available studies do not suggest that this treatment can cause dependence.

Have been observed the following symptoms in relation to drug withdrawal:

Dizziness, tingling, headache, nausea and anxiety.

Most of the withdrawal reactions are mild and self-limiting. Completion of treatment should not be done abruptly.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Side Effects of fluvoxamine     

Like all medicines, fluvoxamine can cause side effects although not everybody gets them.

The frequency of side effects is classified into:

Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data

Nausea, sometimes accompanied by vomiting are the most common symptoms of treatment with fluvoxamine. This effect tends to decrease during the first two weeks treatment.

Common side effects:

General side effects: asthenia (intense physical tiredness), headache, discomfort.

Cardiovascular side effects: palpitations, tachycardia (increased heart rate).

Digestive side effects: abdominal pain, anorexia (loss of appetite), constipation, diarrhea, dry mouth, dyspepsia (digestive disorder).

Neurological side effects: agitation, anxiety, dizziness, insomnia, nervousness, drowsiness, tremor.

Skin side effects: profuse sweating.

Uncommon side effects:

Cardiovascular side effects: hypotension (standing up).

Musculoskeletal side effects: arthralgia (joint pain), myalgia (muscle pain).

Neurological side effects: ataxia (incoordination of voluntary movements), confusion, motor disorders, hallucinations.

Genitourinary side effects: Ejaculation disorders (retrograde ejaculation).

Skin side effects: allergic reactions (including rash, itching, angioedema).

Rare side effects:

Digestive side effects: disorders of liver function.

Neurological side effects: seizures, mania, psychomotor agitation/akathisia (inability to remain quiet).

Genitourinary side effects: spontaneous secretion of milk from the nipple (galactorrhea).

Skin side effects: photosensitivity (allergy to light).

Other adverse events observed during post-marketing:

Very rare side effects:

- Weight gain or loss.
- Serotonin syndrome (characterized by the presence of seizures, coagulation disorders, increased body temperature, headache, respiratory insufficiency, etc.),
- Episodes such as the so-called neuroleptic malignant syndrome (It is characterized by an increased body temperature, disturbance of consciousness, muscular rigidity, intense sweating, abnormal movements, heart rhythm disturbances, etc.),
- Hyponatremia (low sodium in the blood),
- Metabolic disorders (syndrome of inappropriate antidiuretic hormone secretion) and hemorrhages.
- Tingling, sexual disorders (anorgasmia) and altered taste.

This list does not include all adverse reactions associated with the use of fluvoxamine, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.

If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.

If any of the side effects gets serious, tell your doctor or pharmacist.

List of brands containing fluvoxamine     

This page contains a list of brands of authorized pharmaceutical specialties of the active principle fluvoxamine in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Warning:

With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.

Australia:     

APO-FLUVOXAMINE 50 mg, tablets
APO-FLUVOXAMINE 100 mg, tablets
APOTEX-FLUVOXAMINE 50 mg, tablets
APOTEX-FLUVOXAMINE 100 mg, tablets
CHEMMART FLUVOXAMINE 50 mg, tablets
CHEMMART FLUVOXAMINE 100 mg, tablets
FAVERIN 50 mg, tablets
FAVERIN 100 mg, tablets
FLUVOXAMINE GA 50 mg, tablets
FLUVOXAMINE GA 100 mg, tablets
LUVOX 50 mg, tablets
LUVOX 100 mg, tablets
MOVOX 50 mg, tablets
MOVOX 100 mg, tablets
TERRY WHITE CHEMISTS FLUVOXAMINE 50 mg, tablets
TERRY WHITE CHEMISTS FLUVOXAMINE 100 mg, tablets
VOXAM 50 mg, tablets
VOXAM 100 mg, tablets

Brazil:     

LUVOX 100 mg, tablets

Canada:     

ACT FLUVOXAMINE 50 mg, tablets
ACT FLUVOXAMINE 100 mg, tablets
APO-FLUVOXAMINE 50 mg, tablets
APO-FLUVOXAMINE 100 mg, tablets
DOM-FLUVOXAMINE 50 mg, tablets
DOM-FLUVOXAMINE 100 mg, tablets
LUVOX 50 mg, tablets
LUVOX 100 mg, tablets
NOVO-FLUVOXAMINE 50 mg, tablets
NOVO-FLUVOXAMINE 100 mg, tablets
PHL-FLUVOXAMINE 50 mg, tablets
PHL-FLUVOXAMINE 100 mg, tablets
PMS-FLUVOXAMINE 50 mg, tablets
PMS-FLUVOXAMINE 100 mg, tablets
PRO DOC FLUVOXAMINE-50 50 mg, tablets
PRO DOC FLUVOXAMINE-100 100 mg, tablets
RATIO-FLUVOXAMINE 50 mg, tablets
RATIO-FLUVOXAMINE 100 mg, tablets
RIVA-FLUVOX 50 mg, tablets
RIVA-FLUVOX 100 mg, tablets
SANDOZ FLUVOXAMINE 50 mg, tablets
SANDOZ FLUVOXAMINE 100 mg, tablets

France:     

FLOXYFRAL 50 mg, tablets
FLOXYFRAL 100 mg, tablets
FLUVOXAMINE ACTAVIS 50 mg, tablets
FLUVOXAMINE ACTAVIS 100 mg, tablets
FLUVOXAMINE EG 50 mg, tablets
FLUVOXAMINE EG 100 mg, tablets
FLUVOXAMINE MYLAN 50 mg, tablets
FLUVOXAMINE MYLAN 100 mg, tablets
FLUVOXAMINE SANDOZ 50 mg, tablets
FLUVOXAMINE SANDOZ 100 mg, tablets
FLUVOXAMINE TEVA 50 mg, tablets
FLUVOXAMINE TEVA 100 mg, tablets

Germany:     

FEVARIN 50 mg, tablets
FEVARIN 100 mg, tablets
FLUVOXAMIN AL 50 mg, tablets
FLUVOXAMIN AL 100 mg, tablets
FLUVOXAMIN-NEURAXPHARM 50 mg, tablets
FLUVOXAMIN-NEURAXPHARM 100 mg, tablets
FLUVOXAMIN-RATIOPHARM 50 mg, tablets

India:     

EXAME 50 mg, tablets
EXAME 100 mg, tablets
FLUVATOR 50 mg, tablets
FLUVATOR 100 mg, tablets
FLUVOXIN 50 mg, tablets
FLUVOXIN 100 mg, tablets
FLUVOXIN-CR 50 mg, tablets
FOXA 50 mg, tablets
FOXA 100 mg, tablets
PSYVOXYN 50 mg, tablets
PSYVOXYN 100 mg, tablets
REVILIFE 50 mg, tablets
REVILIFE 100 mg, tablets
SOREST 50 mg, tablets
SOREST 100 mg, tablets
UVOX 50 mg, tablets
UVOX 100 mg, tablets
VOXAMIN 50 mg, tablets
VOXAMIN 100 mg, tablets
VOXIDEP 25 mg, tablets
VOXIDEP 50 mg, tablets
VOXIDEP 100 mg, tablets

Italy:     

DUMIROX 50 mg, tablets
DUMIROX 100 mg, tablets
FEVARIN 50 mg, tablets
FEVARIN 100 mg, tablets
FLUVOXAMINA EG 50 mg, tablets
FLUVOXAMINA EG 100 mg, tablets
MAVERAL 50 mg, tablets
MAVERAL 100 mg, tablets

Japan:     

DEPROMEL 25 mg, tablets
DEPROMEL 50 mg, tablets
DEPROMEL 75 mg, tablets
FLUVOXAMINE AMEL 25 mg, tablets
FLUVOXAMINE AMEL 50 mg, tablets
FLUVOXAMINE AMEL 75 mg, tablets
FLUVOXAMINE CH 25 mg, tablets
FLUVOXAMINE CH 50 mg, tablets
FLUVOXAMINE CH 75 mg, tablets
FLUVOXAMINE EMEC 25 mg, tablets
FLUVOXAMINE EMEC 50 mg, tablets
FLUVOXAMINE EMEC 75 mg, tablets
FLUVOXAMINE FFP 25 mg, tablets
FLUVOXAMINE FFP 50 mg, tablets
FLUVOXAMINE FFP 75 mg, tablets
FLUVOXAMINE JG 25 mg, tablets
FLUVOXAMINE JG 50 mg, tablets
FLUVOXAMINE JG 75 mg, tablets
FLUVOXAMINE KYORIN 25 mg, tablets
FLUVOXAMINE KYORIN 50 mg, tablets
FLUVOXAMINE KYORIN 75 mg, tablets
FLUVOXAMINE NICHI-IKO 25 mg, tablets
FLUVOXAMINE NICHI-IKO 50 mg, tablets
FLUVOXAMINE NICHI-IKO 75 mg, tablets
FLUVOXAMINE NP 25 mg, tablets
FLUVOXAMINE NP 50 mg, tablets
FLUVOXAMINE NP 75 mg, tablets
FLUVOXAMINE PFIZER 50 mg, tablets
FLUVOXAMINE PFIZER 75 mg, tablets
FLUVOXAMINE PFIZETR 25 mg, tablets
FLUVOXAMINE SAWAI 25 mg, tablets
FLUVOXAMINE SAWAI 50 mg, tablets
FLUVOXAMINE SAWAI 75 mg, tablets
FLUVOXAMINE TAKATA 25 mg, tablets
FLUVOXAMINE TAKATA 50 mg, tablets
FLUVOXAMINE TAKATA 75 mg, tablets
FLUVOXAMINE TCK 25 mg, tablets
FLUVOXAMINE TCK 50 mg, tablets
FLUVOXAMINE TCK 75 mg, tablets
FLUVOXAMINE TOWA 25 mg, tablets
FLUVOXAMINE TOWA 50 mg, tablets
FLUVOXAMINE TOWA 75 mg, tablets
FLUVOXAMINE TYK 25 mg, tablets
FLUVOXAMINE TYK 50 mg, tablets
FLUVOXAMINE TYK 75 mg, tablets
FLUVOXAMINE YD 25 mg, tablets
FLUVOXAMINE YD 50 mg, tablets
FLUVOXAMINE YD 75 mg, tablets
LUVOX 25 mg, tablets
LUVOX 50 mg, tablets
LUVOX 75 mg, tablets

Mexico:     

LUVOX 100 mg, 15 & 30 tablets
VUMINIX 50 mg, 10, 20, 30 & 100 tablets
VUMINIX 100 mg, 30 & 100 tablets

Pakistan:     

B-VERT 50 mg, tablets
B-VERT 100 mg, tablets
FAVERIN 50 mg, tablets
FAVERIN 100 mg, tablets
FLOMIN 50 mg, tablets
FLOMIN 100 mg, tablets
HEXAL 100 mg, tablets
MEDUXA 50 mg, tablets
MEDUXA 100 mg, tablets
MILD 25 mg, tablets
MILD 75 mg, tablets
VOXAMINE 50 mg, tablets
VOXAMINE 100 mg, tablets

Spain:     

DUMIROX 50 mg, 30 tablets
DUMIROX 100 mg, 30 tablets
FLUVOXAMINA SANDOZ 50 mg, 30 tablets
FLUVOXAMINA SANDOZ 100 mg, 30 tablets
FLUVOXAMINA TEVA 50 mg, 30 tablets
FLUVOXAMINA TEVA 100 mg, 30 tablets

Turkey:     

FAVERIN 100 mg, tablets
FLUVAMTEVA 100 mg, tablets
REVOXIN 100 mg, tablets

United Kingdom:     

FAVERIN 100 mg, tablets
FAVERIN 50 mg, tablets
FLUVOXAMINE AAH PHARMA 50 mg, tablets
FLUVOXAMINE AAH PHARMA 100 mg, tablets
FLUVOXAMINE ALLIANCE HEALTHCARE 50 mg, tablets
FLUVOXAMINE ALLIANCE HEALTHCARE 100 mg, tablets
FLUVOXAMINE KENT PHARMA 50 mg, tablets
FLUVOXAMINE TEVA 50 mg, tablets
FLUVOXAMINE TEVA 100 mg, tablets
FLUVOXAMINE WOCKHARDT 50 mg, tablets
FLUVOXAMINE WOCKHARDT 100 mg, tablets

U.S.A. and Puerto Rico:     

FLUVOXAMINE APOTEX 25 mg, 100 tablets
FLUVOXAMINE APOTEX 50 mg, 100 tablets
FLUVOXAMINE APOTEX 100 mg, 100 tablets
FLUVOXAMINE BARR 25 mg, 100 tablets
FLUVOXAMINE BARR 50 mg, 100 tablets
FLUVOXAMINE BARR 100 mg, 100 tablets
FLUVOXAMINE BAYPHARMA 25 mg, 100 tablets
FLUVOXAMINE BAYPHARMA 50 mg, 100 tablets
FLUVOXAMINE BAYPHARMA 100 mg, 100 tablets
FLUVOXAMINE CARACO 25 mg, 100 tablets
FLUVOXAMINE CARACO 50 mg, 100 tablets
FLUVOXAMINE CARACO 100 mg, 100 tablets
FLUVOXAMINE EON LABS 25 mg, 30 & 100 tablets
FLUVOXAMINE EON LABS 50 mg, 30 & 100 tablets
FLUVOXAMINE EON LABS 100 mg, 30 & 100 tablets
FLUVOXAMINE GENPHARM 50 mg, 50 & 100 tablets
FLUVOXAMINE GENPHARM 100 mg, 50 & 100 tablets
FLUVOXAMINE IVAX 25 mg, 100 tablets
FLUVOXAMINE IVAX 50 mg, 100 tablets
FLUVOXAMINE IVAX 100 mg, 100 tablets
FLUVOXAMINE MYLAN 25 mg, 100 tablets
FLUVOXAMINE MYLAN 50 mg, 100 tablets
FLUVOXAMINE MYLAN 100 mg, 100 tablets
FLUVOXAMINE NCS HEALTHCARE OF KY 100 mg, 30 tablets
FLUVOXAMINE STAT RX USA 25 mg, 30, 60 & 90 tablets
FLUVOXAMINE SYNTHON 25 mg, 30 & 100 tablets
FLUVOXAMINE SYNTHON 50 mg, 30 & 100 tablets
FLUVOXAMINE SYNTHON 100 mg, 30 & 100 tablets
FLUVOXAMINE TEVA 25 mg, 100 tablets
FLUVOXAMINE TEVA 50 mg, 100 tablets
FLUVOXAMINE TEVA 100 mg, 100 tablets
FLUVOXAMINE UDL 50 mg, 100 tablets
FLUVOXAMINE UDL 100 mg, 100 tablets
LUVOX CR 100 mg, 30 extended release capsules
LUVOX CR 150 mg, 30 extended release capsules

Page updated: December 10, 2010.